Aligos Therapeutics, Inc. (ALGS) Free cash flow 2019–2024
Aligos Therapeutics, Inc. (ALGS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$80.9MFY2024 · since FY2019: -$49.6M → -$80.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$80.9M | -2.4% |
| FY2023 | -$79.0M | +1.6% |
| FY2022 | -$80.3M | +31.1% |
| FY2021 | -$116.6M | -52.7% |
| FY2020 | -$76.3M | -54.0% |
| FY2019 | -$49.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice